Myocardial Remodeling in Early Chronic Kidney Disease-Mineral and Bone Disorder Model with Low Bone Turnover

被引:0
|
作者
Bogdanova, Evdokia [1 ]
Sadykov, Airat [2 ]
Ivanova, Galina [3 ]
Zubina, Irina [1 ]
Beresneva, Olga [1 ]
Galkina, Olga [1 ]
Parastaeva, Marina [1 ]
Sharoyko, Vladimir [4 ]
Dobronravov, Vladimir [1 ]
机构
[1] Pavlov Univ, Res Inst Nephrol, St Petersburg 197022, Russia
[2] Pavlov Univ, Raisa Gorbacheva Mem Res Inst Pediat Oncol Hematol, St Petersburg 197022, Russia
[3] Physiol Pavlov Inst Physiol, Lab Cardiovasc & Lymphat Syst, St Petersburg 199034, Russia
[4] Pavlov Univ, Dept Gen & Bioorgan Chem, St Petersburg 197022, Russia
来源
KIDNEY AND DIALYSIS | 2023年 / 3卷 / 04期
基金
俄罗斯基础研究基金会;
关键词
chronic kidney disease-mineral and bone disorder; myocardial remodeling; phosphate; calcineurin; ERK1/2; PiT-2; Jagged1; Patched; 1; Hes1; Lgr4; LEFT-VENTRICULAR HYPERTROPHY; MAGNETIC-RESONANCE-SPECTROSCOPY; UREMIC CARDIOMYOPATHY; MOLECULAR-MECHANISMS; GENE-EXPRESSION; RENAL-FAILURE; PHOSPHATE; FIBROSIS; PATHWAY; OPPORTUNITIES;
D O I
10.3390/kidneydial3040028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease-mineral and bone disorder (CKD-MBD) plays a significant role in causing cardiovascular morbidity and mortality related to CKD. CKD-MBD has been studied during advanced stages when changes in inorganic phosphate (Pi) and its hormonal regulation are obvious. The initial phases of myocardial remodeling (MR) in early CKD-MBD remain poorly understood. We induced mild CKD-MBD in spontaneously hypertensive rats using 3/4 nephrectomy. Animals were fed standard chow, containing 0.6% phosphate. In each animal, we analyzed indices of chronic kidney injury, bone turnover and Pi exchange, and assessed the myocardial histology and gene expression profile. Applied CKD-MBD models corresponded to human CKD S1-2 with low bone turnover and without an increase in systemic Pi-regulating factors (parathyroid hormone and fibroblast growth factor 23). In mild CKD-MBD models, we found MR features characterized by cardiomyocyte hypertrophy, interstitial and perivascular fibrosis, intramyocardial artery media thickening, along with alterations in Ppp3ca, Mapk1, Jag1, Hes1, Ptch1, Numb, Lgr4 and Bmp4 genes. Among other genes, the down-regulation of Jag1 was most tightly associated with either myocardial hypertrophy or fibrosis. Myocardial alterations concurrently occurred with mild CKD-MBD and comprised fibrosis preceding cardiomyocyte hypertrophy. The histological features of MR were associated with myocardial P accumulation in settings of low bone turnover, prior to a response of systemic Pi-regulating factors and with alterations in calcineurin, ERK1/2, Notch, BMP and Hedgehog genes.
引用
收藏
页码:322 / 334
页数:13
相关论文
共 50 条
  • [21] NEW PLAYERS IN THE CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER
    Perna, A. F.
    Coppola, A.
    Borriello, M.
    Ingrosso, D.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S97 - S97
  • [22] Pediatric Patients with Chronic Kidney Disease-Mineral Bone Disorder
    Juhi Kumar
    Susan L. Furth
    Bradley A. Warady
    Clinical Reviews in Bone and Mineral Metabolism, 2012, 10 (3): : 219 - 234
  • [23] Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder
    Hanudel, Mark R.
    Salusky, Isidro B.
    CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (03) : 198 - 206
  • [24] Newly Developed Rat Model of Chronic Kidney Disease-Mineral Bone Disorder
    Watanabe, Kentaro
    Fujii, Hideki
    Goto, Shunsuke
    Nakai, Kentaro
    Kono, Keiji
    Watanabe, Shuhei
    Shinohara, Masami
    Nishi, Shinichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (02) : 170 - 177
  • [25] Chronic kidney disease-mineral and bone disorder: a complex scenario
    Mejia, N.
    Roman-Garcia, P.
    Miar, A. B.
    Tavira, B.
    Cannata-Andia, J. B.
    NEFROLOGIA, 2011, 31 (05): : 514 - 519
  • [26] Cinacalcet Hydrochloride in Chronic Kidney Disease-Mineral Bone Disorder
    Yokoyama, Keitaro
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (09): : 1405 - 1408
  • [27] Chronic Kidney Disease-Mineral and Bone Disorder KDIGO Guidelines
    Khwaja, A.
    NEPHRON CLINICAL PRACTICE, 2010, 116 (01): : C25 - C26
  • [28] Bone health in chronic kidney disease-mineral and bone disease
    Gal-Moscovici, Anca
    Sprague, Stuart M.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2007, 14 (01) : 27 - 36
  • [29] Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder
    Jiang, Jian-Qing
    Lin, Shan
    Xu, Peng-Cheng
    Zheng, Zhen-Feng
    Jia, Jun-Ya
    NEPHROLOGY, 2011, 16 (06) : 588 - 594
  • [30] Metformin prevents from severe kidney failure, vascular calcification and high bone turnover disease in a rat model for chronic kidney disease-mineral and bone disorder
    D'Haese, P.
    Vervaet, B.
    Brand, K.
    Gottwald-Hostalek, U.
    Dams, G.
    Verhulst, A.
    Lalau, J. -D.
    Said, K.
    De Broe, M. E.
    Neven, E.
    DIABETOLOGIA, 2016, 59 : S485 - S486